While dysregulated MYBL2 expression has been linked to genomic instability and poor outcomes in multiple carcinomas, including lung, the pro-tumor transcriptional programs regulated by MYBL2 have remained elusive (22). This evidence concerns the gene MYBL2 and neoplasm.